Emergence of Escherichia coli isolates producing conjugative plasmid-mediated DHA-1 β-lactamase in a Korean university hospital

Journal of Hospital Infection

Volumn 63, Issue 4, 2006, Pages 459-464

  Song, W ^a,c   Kim, J S ^a   Kim, H S ^a   Jeong, S H ^b,c   Yong, D ^c   Lee, K M ^a  

^a Hallym University College of Medicine   (South Korea)

^b Kosin University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Conjugative; DHA 1; Escherichia coli

Indexed keywords

AMIKACIN; AZIDE; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOXITIN; CEFPROZIL; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; GENOMIC DNA; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN DHA 1; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BILIARY TRACT INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; DNA SEQUENCE; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; GENETIC CODE; HUMAN; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; KOREA; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; AGED; BETA-LACTAMASES; CONJUGATION, GENETIC; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; KOREA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS;

EID: 33745727908     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.03.009     Document Type: Article

References (21)

1. Mulvey M.R., Bruce E., Boyd D.A., et al. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 49 (2005) 358-365
2. Bauernfeind A., Chong Y., and Schweighar S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17 (1989) 316-321
3. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 46 (2002) 1-11
4. Hanson N.D. AmpC β-lactamases: what do we need to know for the future?. J Antimicrob Chemother 52 (2003) 2-4
5. Barnaud G., Arlet G., Verdet C., Gaillot O., Lagrange P.H., and Philippon A. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 42 (1998) 2352-2358
6. Yan J.J., Ko W.C., Jung Y.C., Chuang C.L., and Wu J.J. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol 40 (2002) 3121-3126
7. Fortineau N., Poirel L., and Nordmann P. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J Antimicrob Chemother 47 (2001) 207-210
8. Reisbig M.D., and Hanson N.D. The ACT-1 plasmid-encoded AmpC β-lactamase is inducible: detection in a complex β-lactamase background. J Antimicrob Chemother 49 (2002) 557-560
9. Nakano R., Okamoth R., Nakano Y., et al. CFE-1, a novel plasmid-encoded AmpC β-lactamase with an ampR gene originating from Citrobacter freundii. Antimicrob Agents Chemother 48 (2004) 1151-1158
10. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., and Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii (1987) 302-306
11. Sambrook J., Fritsch E.F., and Maniatus T. Molecular cloning: a laboratory manual. 2nd edn. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
12. Matthew W., Harris M., Marshall M.J., and Rose G.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88 (1975) 169-178
13. Takahashi S., and Nagano Y. Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J Clin Microbiol 20 (1984) 608-613
14. Perez-Perez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40 (2002) 2153-2162
15. De Champ C., Sirot D., Chanal C., Bonnet R., Sirot J., and The French Study Group. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. Antimicrob Agents Chemother 44 (2000) 3177-3179
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th edn. (2003), National Committee for Clinical Laboratory Standards, Wayne, PA Approved Standard M7-A6
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement. CLSI Document M100-S15 (2005), Clinical and Laboratory Standards Institute, Wayne, PA
18. Livermore D.M. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 34 (1995) 557-584
19. Song W., Kim J.S., Kim M.N., et al. Occurrence and genotypic distributions of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea. Korean J Lab Med 22 (2002) 410-416
20. Yan J.J., Ko W.C., Tsai S.H., Wu H.M., Jin Y.T., and Wu J.J. Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in Southern Taiwan. J Clin Microbiol 38 (2000) 4320-4325
21. Coudron P.E. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 43 (2005) 4163-4167